兰索普拉与PPI使用者中相对较低的痛风风险相关:全国性的回顾性研究
Hung-Kai Shih1, Yu-Te Su1, Sy-Jou Chen1
1Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Clinical rheumatology
|June 3, 2025
概括
兰索普拉是一种质子抑制剂 (PPI),与其他PPI相比,显著降低了痛风风险. 这一发现表明,兰索普拉可能是需要PPI治疗和风险高的痛风患者的首选选择.
科学领域:
- 胃肠病学 胃肠病学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 质子抑制剂 (PPI) 与胰岛素耐药性增加有关,这是高尿血症的危险因素.
- 兰索普拉可以通过影响特定基因表达来减轻胰岛素耐药性.
- 了解PPI对痛风风险的不同影响至关重要.
研究的目的:
- 为了比较与兰索普拉与其他PPI相关的痛风风险.
- 评估兰索普拉在预防痛风方面的潜在作用.
主要方法:
- 使用台湾国家医疗保险数据库 (2000-2013) 进行的回顾性队列研究.
- 患者人口统计和并发症的倾向性得分匹配.
- 生存分析和考克斯的比例危险模型来评估痛风风险.
主要成果:
- 与其他 PPI (13.3%) 相比,兰索普拉组的痛风发病率较低 (7.7%).
- 使用兰索普拉显著降低了痛风风险 (调整后危险比,0.64;95% CI,0.56-0.73).
- 跨性别和年龄层 (30岁以上) 一致的发现.
结论:
- 兰索普拉的使用与PPI使用者中出现痛风的风险明显降低.
- 兰索普拉可能是患痛风风险较高的人的首选PPI.
- 进一步的研究可以探索兰索普拉的保护作用背后的机制.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
536
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
536
Peptic Ulcer Disease IV: Management
151
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
151
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
574
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
574
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
450
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
450
Peptic Ulcer Disease I: Introduction
305
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
305
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
709
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
709


